Sezary Syndrome with CD4/CD8 Double-Negative Neoplastic T Cells in Peripheral Blood

被引:2
|
作者
Kageyama, Yuki [1 ,2 ]
Tsuda, Kenshiro [3 ]
Nato, Yuma [1 ]
Nagaharu, Keiki [2 ]
Suzuki, Kazutaka [1 ]
Sawaki, Akihiko [1 ]
Miyashita, Hiroyuki [1 ]
机构
[1] Yokkaichi Municipal Hosp, Dept Hematol, 2-2-37 Shibata, Yokaichi 5108567, Japan
[2] Mie Univ, Dept Hematol & Oncol, Grad Sch Med, 2-174 Edobashi, Tsu, Mie 5148507, Japan
[3] Yokkaichi Municipal Hosp, Dept Dermatol, 2-2-37 Shibata, Yokaichi 5108567, Japan
关键词
MYCOSIS-FUNGOIDES; LYMPHOMA; CONSORTIUM;
D O I
10.1155/2021/5527725
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sezary syndrome is a rare leukemic type of cutaneous T-cell lymphoma characterized by the presence of neoplastic T cells with cerebriform nuclei (Sezary cells) in the skin, lymph nodes, and peripheral blood. Typical Sezary cells have a CD3(+)CD4(+)CD8(-) phenotype; however, in cases of the aberrant loss of antigens on Sezary cells, especially the loss of critically important T-cell antigens such as CD4, there is a possibility of misdiagnosing the disease or underestimating the tumor burden of the disease. Here, we report a rare case of Sezary syndrome with CD4/CD8 double-negative Sezary cells in the peripheral blood. Most of the Sezary cells in the peripheral blood had lost CD4 expression, and we diagnosed the disease and evaluated the tumor burden by multicolor flow cytometry. Intriguingly, the Sezary cells showed a typical CD4(+)CD8(-)CD7(-) phenotype in the skin even though the cells in the peripheral blood lacked CD4. The patient responded well to treatment with bexarotene and narrow-band ultraviolet B therapy. Analysis by multicolor flow cytometry is essential to diagnose this rare type of Sezary syndrome and evaluate the tumor burden.
引用
收藏
页数:5
相关论文
共 50 条
  • [11] Extrathymic CD4/CD8 double positive T cells
    Zuckermann, FA
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 1999, 72 (1-2) : 55 - 66
  • [12] Calyculin A inhibits expression of CD8α but not CD4 in human peripheral blood T cells
    Allam, A
    Illges, H
    IMMUNOBIOLOGY, 2000, 202 (04) : 353 - 362
  • [13] Functional and phenotypic analysis of porcine peripheral blood CD4/CD8 double-positive T cells
    Zuckermann, FA
    Husmann, RJ
    IMMUNOLOGY, 1996, 87 (03) : 500 - 512
  • [14] Gene expression profiles of CD4/CD8 double-positive T cells in porcine peripheral blood
    Okutani, Mie
    Tsukahara, Takamitsu
    Kato, Yoshihiro
    Fukuta, Kikuto
    Inoue, Ryo
    ANIMAL SCIENCE JOURNAL, 2018, 89 (07) : 979 - 987
  • [15] Primary cutaneous aggressive epidermotropic CD4/CD8 double-negative cytotoxic T-cell lymphoma
    Akkari, H.
    Belhadjali, H.
    Mousa, A.
    Yousef, M.
    Zili, J.
    PATHOLOGICA, 2012, 104 (02) : 78 - 81
  • [16] CD8α is an activation marker for a subset of peripheral CD4 T cells
    Kenny, E
    Mason, D
    Saoudi, A
    Pombo, A
    Ramírez, F
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (05) : 1262 - 1271
  • [17] Unravelling the biology of double-positive CD4/CD8αβ T cells in peripheral tissues
    Kong, Wei Yang
    Soderholm, Amelia
    de Oca, Marcela Montes
    Chew, Hui Yi
    Brooks, Andrew
    Cruz, Jazmina
    Wells, James
    JOURNAL OF IMMUNOLOGY, 2024, 212 (01):
  • [18] Heterogeneity in phenotype and function of CD8+and CD4/CD8 double-negative Natural Killer T cell subsets in sooty mangabeys
    Rout, Namita
    Else, James G.
    Yue, Simon
    Connole, Michelle
    Exley, Mark A.
    Kaur, Amitinder
    JOURNAL OF MEDICAL PRIMATOLOGY, 2010, 39 (04) : 224 - 234
  • [19] Recovery of CD4/CD8 double-negative T cells is associated with EBV reactivation after haploidentical hematopoietic stem cell transplantation
    Liu, J.
    Bian, Z.
    Xu, L. -P.
    Chang, Y. -J.
    Wang, Y.
    Zhang, X. -H.
    Huang, X. -J.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S248 - S248
  • [20] CD4/CD8 double-negative early-stage mycosis fungoides with CD30 expression
    Shon, Uri
    Yun, Dea Kwan
    Seong, Gi Hyun
    Park, Byung Cheol
    Kim, Myung Hwa
    Lee, Dong Yoon
    JOURNAL OF CUTANEOUS PATHOLOGY, 2021, 48 (04) : 587 - 589